Ishares Nasdaq Biotechnology (NASDAQ:IBB) Position Boosted by LPL Financial LLC

LPL Financial LLC grew its holdings in Ishares Nasdaq Biotechnology (NASDAQ:IBB) by 209.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 457,854 shares of the financial services provider’s stock after acquiring an additional 310,021 shares during the period. LPL Financial LLC owned about 0.53% of Ishares Nasdaq Biotechnology worth $49,247,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also bought and sold shares of the company. Parametric Portfolio Associates LLC raised its holdings in shares of Ishares Nasdaq Biotechnology by 8.7% in the second quarter. Parametric Portfolio Associates LLC now owns 988 shares of the financial services provider’s stock valued at $306,000 after buying an additional 79 shares during the last quarter. FDx Advisors Inc. increased its stake in shares of Ishares Nasdaq Biotechnology by 49.8% during the third quarter. FDx Advisors Inc. now owns 1,416 shares of the financial services provider’s stock worth $472,000 after acquiring an additional 471 shares during the period. SG Americas Securities LLC increased its stake in shares of Ishares Nasdaq Biotechnology by 1,093.9% during the third quarter. SG Americas Securities LLC now owns 38,242 shares of the financial services provider’s stock worth $12,757,000 after acquiring an additional 35,039 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Ishares Nasdaq Biotechnology by 9.3% during the third quarter. Ameriprise Financial Inc. now owns 101,917 shares of the financial services provider’s stock worth $33,991,000 after acquiring an additional 8,667 shares during the period. Finally, Ruggie Capital Group increased its stake in shares of Ishares Nasdaq Biotechnology by 6.3% during the third quarter. Ruggie Capital Group now owns 13,961 shares of the financial services provider’s stock worth $4,659,000 after acquiring an additional 825 shares during the period. Institutional investors and hedge funds own 62.05% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ IBB traded down $3.14 on Friday, hitting $101.03. The company’s stock had a trading volume of 2,840,400 shares, compared to its average volume of 2,502,108. Ishares Nasdaq Biotechnology has a 12-month low of $94.20 and a 12-month high of $119.30.

WARNING: “Ishares Nasdaq Biotechnology (NASDAQ:IBB) Position Boosted by LPL Financial LLC” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/lpl-financial-llc-acquires-310021-shares-of-ishares-nasdaq-biotechnology-index-ibb.html.

Ishares Nasdaq Biotechnology Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for Ishares Nasdaq Biotechnology (NASDAQ:IBB)

Receive News & Ratings for Ishares Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ishares Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply